Physician profile
Ivan Samcam
NPI 1194131730
$50,570.49
in general payments reported to CMS, 2019-2025
72 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,072 · 2020: $3,111 · 2021: $4,083 · 2022: $4,739 · 2023: $2,443 · 2024: $4,301 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,188 · Travel and Lodging: $1,189 · Entertainment: $124 · Education: $52.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,312.50 |
| Food and Beverage | $10,698.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,187.50 |
| Travel and Lodging | $1,188.90 |
| Entertainment | $124.41 |
| Education | $52.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $17,251.52 | 2020-2025 | Spinejack, Mild Device Kit, Optablate |
| Boston Scientific Corporation | $6,698.22 | 2019-2025 | Intracept, Intracept Rf Probe, General - Pain Management |
| Vertiflex, INC. | $2,510.39 | 2019 | |
| Mml US, INC. | $2,422.93 | 2022-2025 | Reactiv8 |
| Relievant Medsystems, INC. | $2,381.96 | 2020-2023 | Intracept |
| Abbott Laboratories | $1,618.02 | 2019-2025 | Eterna, Proclaim |
| Vertos Medical, INC. | $1,616.67 | 2019-2024 | Mild Device Kit |
| Abbvie INC. | $1,584.77 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Nevro Corp. | $1,325.46 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $1,168.54 | 2021 | |
| Painteq LLC | $689.30 | 2023-2024 | Painteq |
| Medtronic, INC. | $677.52 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Teva Pharmaceuticals USA, INC. | $612.52 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Ucb, INC. | $606.46 | 2023-2025 | Briviact, Zilbrysq |
| Eisai INC. | $563.83 | 2021-2025 |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $550.13 | 2021-2022 | |
| Curonix LLC | $430.53 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Takeda Pharmaceuticals U.S.A., INC. | $415.16 | 2019-2025 | Hyqvia, Gammagard |
| Octapharma USA, INC. | $386.46 | 2023-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Medtronic USA, INC. | $383.77 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $378.78 | 2019-2025 | |
| Tersera Therapeutics LLC | $365.66 | 2019-2022 | |
| Amgen INC. | $347.56 | 2019-2022 | |
| Biotronik Nro, INC. | $332.85 | 2023-2025 | Prospera, Biotronik |
| Collegium Pharmaceutical, INC. | $329.78 | 2019-2021 | |
| Saluda Medical Americas, INC. | $328.22 | 2024-2025 | Evoke |
| Pfizer INC. | $322.87 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $313.56 | 2023-2025 | Ultomiris |
| Ge Healthcare | $298.94 | 2023-2025 | |
| Allergan, INC. | $276.64 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $271.43 | 2023-2024 | Onpattro |
| Radius Health, INC. | $261.28 | 2019-2022 | |
| Vgi Medical, LLC | $243.18 | 2022 | |
| Foundation Fusion Solutions, LLC | $208.77 | 2024-2025 | |
| Nalu Medical, INC. | $166.91 | 2023-2025 | Nalu Neurostimulation System |
| Lilly USA, LLC | $156.87 | 2022-2024 | Amyvid, Kisunla, Reyvow |
| Argenx US, INC. | $156.05 | 2023-2024 | Vyvgart Hytrulo |
| Fidia Pharma USA INC. | $132.04 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $131.00 | 2021 | |
| Lundbeck LLC | $120.38 | 2024-2025 | Vyepti |
| Globus Medical, INC. | $96.61 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $93.11 | 2019 | |
| Merit Medical Systems INC | $86.62 | 2021-2023 | Stabilit |
| Averitas Pharma INC. | $83.45 | 2023-2025 | Qutenza |
| Otsuka America Pharmaceutical, INC. | $79.37 | 2023-2024 | Nuedexta, Rexulti |
| Tanabe Pharma America, INC. | $74.41 | 2023-2025 | Radicava |
| Neurocrine Biosciences, INC. | $69.93 | 2023-2024 | Ingrezza, Ongentys |
| Forte Bio-Pharma LLC | $69.50 | 2019 | |
| Horizon Therapeutics Plc | $69.40 | 2019 | |
| Azurity Pharmaceuticals, INC. | $67.35 | 2023-2024 | Horizant, Horizant |
| Zyla Life Sciences, INC. | $58.10 | 2019-2020 | |
| Orexo US, INC. | $54.52 | 2019-2020 | |
| Kaleo, INC. | $52.96 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $52.52 | 2022 | |
| Spr Therapeutics, INC | $48.47 | 2024-2025 | Sprint Pns System |
| Novartis Pharmaceuticals Corporation | $48.30 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $45.35 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $42.42 | 2025 | |
| Cala Health, INC. | $36.26 | 2025 | Cala Kiq |
| Revance Therapeutics, INC. | $30.53 | 2024 | Daxxify |
| Sk Life Science, INC. | $30.49 | 2025 | |
| West Therapeutics Development, LLC | $30.20 | 2019 | |
| Si-Bone, INC. | $28.98 | 2024 | |
| Mvp Orthopedics INC | $28.80 | 2021 | |
| Upsher-Smith Laboratories LLC | $27.85 | 2023 | |
| Masimo Corporation | $24.38 | 2023 | Patient Safetynet System |
| Promius Pharma LLC | $21.47 | 2019 | |
| Impel Pharmaceuticals INC. | $17.57 | 2023 | Trudhesa |
| Corium, LLC | $17.56 | 2023 | Adlarity |
| Pacira Pharmaceuticals Incorporated | $17.56 | 2023 | Zilretta, Iovera, Exparel |
| Redhill Biopharma INC. | $15.36 | 2021 | |
| Ibsa Pharma INC. | $14.16 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Samcam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.